0001808805-22-000037.txt : 20220415 0001808805-22-000037.hdr.sgml : 20220415 20220415170721 ACCESSION NUMBER: 0001808805-22-000037 CONFORMED SUBMISSION TYPE: 3/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220411 FILED AS OF DATE: 20220415 DATE AS OF CHANGE: 20220415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Weld Gwen E CENTRAL INDEX KEY: 0001378831 FILING VALUES: FORM TYPE: 3/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-39434 FILM NUMBER: 22830562 MAIL ADDRESS: STREET 1: C/O ISILON SYSTEMS, INC. STREET 2: 3101 WESTERN AVENUE CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc. CENTRAL INDEX KEY: 0001808805 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 BUSINESS PHONE: 206-333-2001 MAIL ADDRESS: STREET 1: 2701 EASTLAKE AVE EAST CITY: SEATTLE STATE: WA ZIP: 98102 FORMER COMPANY: FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III DATE OF NAME CHANGE: 20200408 3/A 1 wf-form3a_165005682403411.xml FORM 3/A X0206 3/A 2022-04-11 2022-04-13 0 0001808805 Nautilus Biotechnology, Inc. NAUT 0001378831 Weld Gwen E C/O NAUTILUS BIOTECHNOLOGY, INC. 2701 EASTLAKE AVENUE EAST SEATTLE WA 98102 0 1 0 0 Chief People Officer Stock Option (Right to Buy) 1.14 2030-10-15 Common Stock 4535.0 D Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan (the "Plan")) through each vesting date, one twenty-fourth (1/24th) of the shares subject to the Option shall vest each month over the twenty-four (24) months following the Vesting Commencement Date (as defined below) on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is September 29, 2020. Form 3 amended to reflect stock option held by reporting person. /s/ Matthew B. Murphy, as Attorney-in-Fact 2022-04-15